Page last updated: 2024-09-05

lapatinib and valdecoxib

lapatinib has been researched along with valdecoxib in 1 studies

Compound Research Comparison

Studies
(lapatinib)
Trials
(lapatinib)
Recent Studies (post-2010)
(lapatinib)
Studies
(valdecoxib)
Trials
(valdecoxib)
Recent Studies (post-2010) (valdecoxib)
1,9193051,4423757186

Protein Interaction Comparison

ProteinTaxonomylapatinib (IC50)valdecoxib (IC50)
Cytochrome c oxidase subunit 2Homo sapiens (human)1.1
Carbonic anhydrase 1Homo sapiens (human)0.1915
Carbonic anhydrase 2Homo sapiens (human)1.0086
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)2.927
Sodium-dependent noradrenaline transporter Homo sapiens (human)2.927
Prostaglandin G/H synthase 2Homo sapiens (human)0.0631
Carbonic anhydrase 9Homo sapiens (human)0.027
Carbonic anhydrase 4Bos taurus (cattle)0.2658

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for lapatinib and valdecoxib

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016